Higher mortality in heterozygous neuropilin-1 mice after cardiac pressure overload

Biochemical and Biophysical Research Communications

Volumn 370, Issue 2, 2008, Pages 317-321

  Li, Fei ^a,c   Zhao, Hui ^a   Liao, Yulin ^a,b   Takashima, Seiji ^a   Asano, Yoshihiro ^a   Shintani, Yasunori ^a   Hori, Masatsugu ^a   Kitakaze, Masafumi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiomyocytes; Heart failure; Heterozygote; Mouse; Neuropilin 1; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; NEUROPILIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART CELL CULTURE; HEART FAILURE; HEART LEFT VENTRICLE MUSCLE; MALE; MORTALITY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CONSTRICTION; HEART FAILURE; HEART VENTRICLES; HETEROZYGOTE; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; NEUROPILIN-1; PRESSURE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MURINAE; MUS; RATTUS;

EID: 42249107652     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.096     Document Type: Article

References (20)

1. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., and Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8 (2002) 35-40
2. Li H.L., Liu C., de Couto G., Ouzounian M., Sun M., Wang A.B., Huang Y., He C.W., Shi Y., Chen X., Nghiem M.P., Liu Y., Chen M., Dawood F., Fukuoka M., Maekawa Y., Zhang L., Leask A., Ghosh A.K., Kirshenbaum L.A., and Liu P.P. Curcumin prevents and reverses murine cardiac hypertrophy. J. Clin. Invest. 118 (2008) 879-893
3. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., Ehler E., Kakkar V.V., Stalmans I., Mattot V., Perriard J.C., Dewerchin M., Flameng W., Nagy A., Lupu F., Moons L., Collen D., D'Amore P.A., and Shima D.T. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5 (1999) 495-502
4. Rottbauer W., Just S., Wessels G., Trano N., Most P., Katus H.A., and Fishman M.C. VEGF-PLCgamma1 pathway controls cardiac contractility in the embryonic heart. Genes Dev. 19 (2005) 1624-1634
5. Yoon Y.S., Uchida S., Masuo O., Cejna M., Park J.S., Gwon H.C., Kirchmair R., Bahlman F., Walter D., Curry C., Hanley A., Isner J.M., and Losordo D.W. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111 (2005) 2073-2085
6. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 (1998) 735-745
7. Takashima S., Kitakaze M., Asakura M., Asanuma H., Sanada S., Tashiro F., Niwa H., Miyazaki Ji J., Hirota S., Kitamura Y., Kitsukawa T., Fujisawa H., Klagsbrun M., and Hori M. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA 99 (2002) 3657-3662
8. Walsh K., and Shiojima I. Cardiac growth and angiogenesis coordinated by inter tissue interactions. J. Clin. Invest. 117 (2007) 3176-3179
9. Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., Colucci W.S., and Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115 (2005) 2108-2118
10. Izumiya Y., Shiojima I., Sato K., Sawyer D.B., Colucci W.S., and Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47 (2006) 887-893
11. Friehs I., Barillas R., Vasilyev N.V., Roy N., McGowan F.X., and del Nido P.J. Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart. Circulation 114 (2006) I290-I295
12. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., and Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development 126 (1999) 4895-4902
13. Kitsukawa T., Shimizu M., Sanbo M., Hirata T., Taniguchi M., Bekku Y., Yagi T., and Fujisawa H. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19 (1997) 995-1005
14. Fukuda S., Kaga S., Zhan L., Bagchi D., Das D.K., Bertelli A., and Maulik N. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem. Biophys. 44 (2006) 43-49
15. Liao Y., Asakura M., Takashima S., Kato H., Asano Y., Shintani Y., Minamino T., Tomoike H., Hori M., and Kitakaze M. Amlodipine ameliorates myocardial hypertrophy by inhibiting EGFR phosphorylation. Biochem. Biophys. Res. Commun. 327 (2005) 1083-1087
16. Sano M., Minamino T., Toko H., Miyauchi H., Orimo M., Qin Y., Akazawa H., Tateno K., Kayama Y., Harada M., Shimizu I., Asahara T., Hamada H., Tomita S., Molkentin J.D., Zou Y., and Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446 (2007) 444-448
17. Heineke J., Auger-Messier M., Xu J., Oka T., Sargent M.A., York A., Klevitsky R., Vaikunth S., Duncan S.A., Aronow B.J., Robbins J., Cromblehol T.M., and Molkentin J.D. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J. Clin. Invest. 117 (2007) 3198-3210
18. Oh H., Takagi H., Otani A., Koyama S., Kemmochi S., Uemura A., and Honda Y. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. Proc. Natl. Acad. Sci. USA 99 (2002) 383-388
19. Pimentel R.C., Yamada K.A., Kleber A.G., and Saffitz J.E. Autocrine regulation of myocyte Cx43 expression by VEGF. Circ. Res. 90 (2002) 671-677
20. Soker S., Miao H.Q., Nomi M., Takashima S., and Klagsbrun M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J. Cell. Biochem. 85 (2002) 357-368